Replies to post #107020 on Biotech Values

[DewDiligence]

Since NVS has already paid for its share for development costs , why should it pay the development costs again from its share of profit? That seems incorrect. I doubt if the deal is structured that way.

Please see my reply to exwannabe in #msg-55851357.